AstraZeneca Vietnam has received the British Chamber of Commerce's (BritCham) first-ever 50th Anniversary Recognition award for the company's unwavering commitment to innovation, sustainability, and its profound impact on Vietnam's healthcare sector.
This recognition comes as part of the celebration of the 50 years of bilateral relations between the United Kingdom and Vietnam.
|AstraZeneca Vietnam has been honoured with BritCham’s first-ever 50th Anniversary Recognition award |
Nitin Kapoor, chairman and general director of AstraZeneca Vietnam and Asia Area Frontier Markets said, "As a global biopharmaceutical company with British-Swedish heritage and nearly three decades accompanying Vietnam’s health system, we are driven by a shared purpose to build a healthier future and make a lasting impact through innovation and sustainability. We are immensely proud to contribute to the UK-Vietnam partnership and will continue to bring the advances of Britain’s life sciences industry to create positive change for people in Vietnam."
AstraZeneca was ranked number one for invention in Idea Pharma’s 2023 Pharmaceutical Innovation and Invention Index, and has been the leader in terms of industry-sponsored clinical trials in Vietnam.
Out of the $360 million that AstraZeneca has committed to invest in Vietnam by 2030, a significant amount has been dedicated to research and development to further strengthen the country's capabilities and increase patients’ early access to new medicines.
In addition, AstraZeneca Vietnam's commitment to sustainability is evident in its initiatives to promote access to healthcare, protect the environment, and uphold ethics and transparency.
As part of the company’s impactful partnerships with the Ministry of Health and other healthcare organisations, it has run various community investment programmes to promote disease awareness, prevention, and early detection.
To support Vietnam’s sustainable development and net-zero strategy, AstraZeneca recently announced a $50 million investment to plant 22.5 million trees over the next five years as part of the company’s global AZ Forest programme.
Along with other benefits for the economy, local communities, and the environment, this project will help to restore Vietnam’s forests and landscapes, allowing biodiversity to flourish and providing sustainable livelihoods for over 17,000 smallholder farmers.
This award adds to the extensive list of recognitions that AstraZeneca has received in its long-standing collaboration with Vietnam. AstraZeneca has been recognised as one of Vietnam's 100 Best Places to Work for four consecutive years.
|The GREAT Awards programme, organised annually by BritCham, recognises excellence and rewards organisations and individuals who have made significant contributions to the business environment in Vietnam. A wide cross-section of sectors are represented, including education, technology, banking, health, science, and more. |
| ||AstraZeneca to increase early patient access to new medicines in Vietnam |
Last week marked an important step in AstraZeneca’s journey in Vietnam. On his visit to Hanoi, Dr. John L. Perez, senior vice president of the Vaccines and Immune Therapies Unit at AstraZeneca, talked to VIR’s Bich Thuy about the company’s future ambition and ongoing efforts to increase Vietnamese patients’ early access to new medicines.
| ||AstraZeneca honoured in Vietnam’s top 100 best places to work 2022 |
AstraZeneca Vietnam has been recognised as one of Vietnam’s top 100 best places to work in 2022, making it the fourth consecutive year that the company has won the recognition.
| ||MoH and AstraZeneca expand health partnership |
AstraZeneca has taken its long-term partnership with Vietnam’s Ministry of Health to the next level for a resilient and healthy local population.